Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Applications of chemogenomic library screening in drug discovery
Lyn H. Jones, Mark E. Bunnage
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 4, pp. 285-296
Closed Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Opportunities and challenges in phenotypic drug discovery: an industry perspective
John G. Moffat, Fabien Vincent, Jonathan A. Lee, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 8, pp. 531-543
Open Access | Times Cited: 823
Automating drug discovery
Gisbert Schneider
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 2, pp. 97-113
Open Access | Times Cited: 665
Rethinking drug design in the artificial intelligence era
Petra Schneider, W. Patrick Walters, Alleyn T. Plowright, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 5, pp. 353-364
Open Access | Times Cited: 657
Biased signalling: from simple switches to allosteric microprocessors
Jeffrey S. Smith, Robert J. Lefkowitz, Sudarshan Rajagopal
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 4, pp. 243-260
Open Access | Times Cited: 654
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 433
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E. Gryder, Marielle E. Yohe, Hsien-Chao Chou, et al.
Cancer Discovery (2017) Vol. 7, Iss. 8, pp. 884-899
Open Access | Times Cited: 274
Drug Repurposing for Viral Infectious Diseases: How Far Are We?
Beatrice Mercorelli, Giorgio Palù, Arianna Loregian
Trends in Microbiology (2018) Vol. 26, Iss. 10, pp. 865-876
Open Access | Times Cited: 247
TTD: Therapeutic Target Database describing target druggability information
Ying Zhou, Yintao Zhang, Donghai Zhao, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1465-D1477
Open Access | Times Cited: 234
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 201
N-Acylhydrazones as drugs
Sreekanth Thota, Daniel A. Rodrigues, Pedro de Sena Murteira Pinheiro, et al.
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 17, pp. 2797-2806
Closed Access | Times Cited: 176
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L. Lin, Kelli M. Wilson, Michele Ceribelli, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 519
Open Access | Times Cited: 176
Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed Tılahun Muhammed, Esin Aki
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 3, pp. 480-495
Closed Access | Times Cited: 95
Progress towards a public chemogenomic set for protein kinases and a call for contributions
David H. Drewry, Carrow I. Wells, David Andrews, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0181585-e0181585
Open Access | Times Cited: 161
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
Andrés Pizzorno, Blandine Padey, Olivier Terrier, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115
Genotoxicity testing: progress and prospects for the next decade
Hasan Türkez, Mehmet Enes Arslan, Özlem Özdemir Tozlu
Expert Opinion on Drug Metabolism & Toxicology (2017) Vol. 13, Iss. 10, pp. 1089-1098
Closed Access | Times Cited: 108
Computational Methodologies in the Exploration of Marine Natural Product Leads
Florbela Pereira, João Aires‐de‐Sousa
Marine Drugs (2018) Vol. 16, Iss. 7, pp. 236-236
Open Access | Times Cited: 94
The utility of target-based discovery
Glenn Croston
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 5, pp. 427-429
Open Access | Times Cited: 93
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification
Carrow I. Wells, Hassan Al‐Ali, David Andrews, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 566-566
Open Access | Times Cited: 93
Target 2035 – update on the quest for a probe for every protein
Susanne Müller, Suzanne Ackloo, Arij Al Chawaf, et al.
RSC Medicinal Chemistry (2021) Vol. 13, Iss. 1, pp. 13-21
Open Access | Times Cited: 69
Applications of Virtual Screening in Bioprospecting: Facts, Shifts, and Perspectives to Explore the Chemo-Structural Diversity of Natural Products
Kauê Santana da Costa, Lidiane Diniz do Nascimento, Anderson Lima e Lima, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 66
Advances in high‐throughput mass spectrometry in drug discovery
María Emilia Dueñas, Rachel E. Heap, Melanie Leveridge, et al.
EMBO Molecular Medicine (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 66
Use of artificial intelligence to enhance phenotypic drug discovery
Sophia Malandraki-Miller, Paul R. Riley
Drug Discovery Today (2021) Vol. 26, Iss. 4, pp. 887-901
Closed Access | Times Cited: 59
Encoding and display technologies for combinatorial libraries in drug discovery: The coming of age from biology to therapy
Yu Fan, Ruibing Feng, Xinya Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3362-3384
Open Access | Times Cited: 12
Systems Pharmacology: Defining the Interactions of Drug Combinations
J. G. Coen van Hasselt, Ravi Iyengar
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 21-40
Open Access | Times Cited: 79
PI3K/Akt Cooperates with Oncogenic Notch by Inducing Nitric Oxide-Dependent Inflammation
Santiago Nahuel Villegas, Rita Gombos, Lucia García-López, et al.
Cell Reports (2018) Vol. 22, Iss. 10, pp. 2541-2549
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top